Categories AlphaGraphs, Earnings, Health Care
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also provided guidance for fiscal 2022.
The Indianapolis-based pharmaceutical company said its revenues moved up 2% year-over-year to $6.94 billion in the third quarter as worldwide volumes increased by 13%.
The positive top-line performance translated into a 12% increase in net earnings, on an adjusted basis, to $1.98 per share. Unadjusted profit increased to $1.45 billion or $1.61 per share from $1.11 billion or $1.22 per share in the third quarter of 2021.
Check this space to read management/analysts’ comments on Eli Lilly’s Q3 2022 earnings
“With four more launches expected by the end of next year and a potential major new indication for tirzepatide, Lilly continues to make progress for patients with unaddressed medical needs through our significant commitment to invest in R&D, welcome the best talent, and turn breakthroughs in our labs into medicines for people around the world,” said David Ricks, CEO of Eli Lilly.
Prior Performance
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
